Dynamic output and control of the hypothalamic-pituitary-adrenal axis in critical illness and major surgery

British Journal of Anaesthesia

Volumn 111, Issue 3, 2013, Pages 347-360

  Gibbison, B ^a,b   Angelini, G D ^c,d   Lightman, S L ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Bristol Heart Institute   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

adrenal cortex; cortisol binding globulin; critical care; hormones, adrenocorticotrophic

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ARGIPRESSIN; BETAMETHASONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; FLUDROCORTISONE; GLOBULIN; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 6; METHYLPREDNISOLONE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADENOHYPOPHYSIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BINDING AFFINITY; CHRONIC DISEASE; CIRCADIAN RHYTHM; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; EPIGENETICS; HEART SURGERY; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INNERVATION; INTENSIVE CARE; MAJOR SURGERY; PARAVENTRICULAR THALAMIC NUCLEUS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BINDING; SECONDARY INFECTION; SEPSIS; SIDE EFFECT; SIGNAL TRANSDUCTION; SUPERINFECTION; SUPRACHIASMATIC NUCLEUS; T LYMPHOCYTE; TREATMENT DURATION; ULTRADIAN RHYTHM;

EID: 84882802825     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet077     Document Type: Review

References (116)

1. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML. Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm.AmJ Physiol 1989; 257: E6-14
2. Droste SK, de Groote L, Atkinson HC, Lightman SL, Reul JM, Linthorst AC. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 2008; 149: 3244-53
3. Conway-Campbell BL, George CL, Pooley JR, et al. The HSP90 molecular chaperone cycle regulates cyclical transcriptional dynamics of the glucocorticoid receptor and its coregulatory molecules CBP/p300 during ultradian ligand treatment. Mol Endocrinol 2011; 25: 944-54
4. Stavreva DA, Wiench M, John S, et al. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol 2009; 11: 1093-102
5. McMaster A, Jangani M, Sommer P, et al. Ultradian cortisol pulsatility encodes a distinct, biologically important signal. PLoS One 2011; 6: E15766
6. Walker JJ, Terry JR, Lightman SL. Origin of ultradian pulsatility in the hypothalamic-pituitary-Adrenal axis. Proc Biol Sci 2010; 277: 1627-33
7. Ulrich-Lai YM, Engeland WC. Hyperinnervation during adrenal regeneration influences the rate of functional recovery. Neuroendocrinology 2000; 71: 107-23
8. Edwards AV, Jones CT. The effect of splanchnic nerve section on the sensitivity of the adrenal cortex to adrenocorticotrophin in the calf. J Physiol 1987; 390: 23-31
9. Engeland WC, Gann DS. Splanchnic nerve stimulation modulates steroid secretion in hypophysectomized dogs. Neuroendocrinology 1989; 50: 124-31
10. Engeland WC, Arnhold MM. Neural circuitry in the regulation of adrenal corticosterone rhythmicity. Endocrine 2005; 28: 325-32
11. Lewis JG, Bagley CJ, Elder PA, Bachmann AW, Torpy DJ. Plasma free cortisol fraction reflects levels of functioning corticosteroidbinding globulin. Clin Chim Acta 2005; 359: 189-94
12. Mickelson KE, Harding GB, Forsthoefel M, Westphal U. Steroidprotein interactions. Human corticosteroid-binding globulin: Characterization of dimer and electrophoretic variants. Biochemistry 1982; 21: 654-60
13. Westphal U. Steroid-protein interactions II. Monogr Endocrinol 1986; 27: 1-603
14. Hammond GL, Smith CL, Goping IS, et al. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci USA 1987; 84: 5153-7
15. Klieber MA, Underhill C, Hammond GL, Muller YA. Corticosteroidbinding globulin, a structural basis for steroid transport and proteinase-Triggered release. J Biol Chem 2007; 282: 29594-603
16. Zhou A, Wei Z, Stanley PL, Read RJ, Stein PE, Carrell RW. The S-To-R transition of corticosteroid-binding globulin and the mechanism of hormone release. J Mol Biol 2008; 380: 244-51
17. Ballard PL. Delivery and transport of glucocorticoids to target cells. Monogr Endocrinol 1979; 12: 25-48
18. Hsu BR, Kuhn RW. The role of the adrenal in generating the diurnal variation in circulating levels of corticosteroid-binding globulin in the rat. Endocrinology 1988; 122: 421-6
19. Lewis JG, Mopert B, Shand BI, et al. Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin. Horm Metab Res 2006; 38: 241-5
20. Cameron A, Henley D, Carrell R, Zhou A, Clarke A, Lightman S. Temperature-responsive release of cortisol from its binding globulin: A protein thermocouple. J Clin Endocrinol Metab 2010; 95: 4689-95
21. Henley DE, Lightman SL. New insights into corticosteroidbinding globulin and glucocorticoid delivery. Neuroscience 2011; 180: 1-8
22. Hammond GL, Smith CL, Paterson NA, Sibbald WJ. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab 1990; 71: 34-9
23. Spiga F, Lightman SL. Dose-dependent effects of corticosterone on nuclear glucocorticoid receptors and their binding to DNA in the brain and pituitary of the rat. Brain Res 2009; 1293: 101-7
24. Becker P, Renkawitz R, Schutz G. Tissue-specific DNaseI hypersensitive sites in the 5′-flanking sequences of the tryptophan oxygenase and the tyrosine aminotransferase genes. Embo J 1984; 3: 2015-20
25. Rigaud G, Roux J, Pictet R, Grange T. In vivo footprinting of rat TAT gene: Dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 1991; 67: 977-86
26. Truss M, Chalepakis G, Beato M. Interplay of steroid hormone receptors and transcription factors on the mouse mammary tumor virus promoter. J Steroid Biochem Mol Biol 1992; 43: 365-78
27. McNally JG, Muller WG, Walker D, Wolford R, Hager GL. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells. Science 2000; 287: 1262-5
28. Becker M, Baumann C, John S, et al. Dynamic behavior of transcription factors on a natural promoter in living cells. EMBO Rep 2002; 3: 1188-94
29. George AA, Schiltz RL, Hager GL. Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int J Biochem Cell Biol 2009; 41: 214-24
30. Conway-Campbell BL, Pooley JR, Hager GL, Lightman SL. Molecular dynamics of ultradian glucocorticoid receptor action. Mol Cell Endocrinol 2012; 348: 383-93
31. Yang J, DeFranco DB. Assessment of glucocorticoid receptorheat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking. Mol Endocrinol 1996; 10: 3-13
32. Yang J, Liu J, DeFranco DB. Subnuclear trafficking of glucocorticoid receptors in vitro: Chromatin recycling and nuclear export. J Cell Biol 1997; 137: 523-38
33. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 1990; 249: 1266-72
34. John S, Johnson TA, Sung MH, et al. Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology 2009; 150: 1766-74
35. Groeneweg FL, Karst H, de Kloet ER, Joels M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol 2012; 350: 299-309
36. Lowenberg M, Tuynman J, Bilderbeek J, et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 2005; 106: 1703-10
37. Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8: 473-9
38. Limbourg FP, Huang Z, Plumier JC, et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 2002; 110: 1729-38
39. Bartholome B, Spies CM, Gaber T, et al. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. Faseb J 2004; 18: 70-80
40. Levine S. Maternal and environmental influences on the adrenocortical response to stress in weanling rats. Science 1967; 156: 258-60
41. Feng X, Wang L, Yang S, et al. Maternal separation produces lasting changes in cortisol and behavior in rhesus monkeys. Proc Natl Acad Sci USA 2011; 108: 14312-7
42. Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den BrinkW. Hyperresponsiveness of hypothalamic-pituitary-Adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry 2002; 52: 1102-12
43. Shanks N, Windle RJ, Perks PA, et al. Early-life exposure to endotoxin alters hypothalamic-pituitary-Adrenal function and predisposition to inflammation. Proc Natl Acad Sci U S A 2000; 97: 5645-50
44. Biddie SC, Conway-Campbell BL, Lightman SL. Dynamic regulation of glucocorticoid signalling in health and disease. Rheumatology (Oxford) 2012; 51: 403-12
45. Pariante CM, Lightman SL. The HPA axis in major depression: Classical theories and new developments. Trends Neurosci 2008; 31: 464-8
46. Henley DE, Russell GM, Douthwaite JA, et al. Hypothalamicpituitary- Adrenal axis activation in obstructive sleep apnea: The effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2009; 94: 4234-42
47. Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 63-8
48. Perretti M, Mugridge KG, Becherucci C, Parente L. Evidence that interleukin-1 and lipoxygenase metabolites mediate the lethal effect of complete Freund's adjuvant in adrenalectomized rats. Lymphokine Cytokine Res 1991; 10: 239-43
49. Yang YH, Hutchinson P, Leech M, Morand EF. Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. J Rheumatol 1997; 24: 1758-64
50. Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233: 652-4
51. Sanden S, Tripmacher R, Weltrich R, et al. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases. J Rheumatol 2000; 27: 1265-70
52. Chikanza IC, Kozaci DL. Corticosteroid resistance in rheumatoid arthritis: Molecular and cellular perspectives. Rheumatology (Oxford) 2004; 43: 1337-45
53. Charmandari E, Kino T. Chrousos syndrome: A seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. Eur J Clin Invest 2010; 40: 932-42
54. Silverman MN, Sternberg EM. Neuroendocrine-immune interactions in rheumatoid arthritis: Mechanisms of glucocorticoid resistance. Neuroimmunomodulation 2008; 15: 19-28
55. De Iudicibus S, Franca R, Martelossi S, Ventura A, Decorti G. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011; 17: 1095-108
56. Bhavsar P, Hew M, Khorasani N, et al. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 2008; 63: 784-90
57. Hew M, Bhavsar P, Torrego A, et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006; 174: 134-41
58. Venkataraman S, Munoz R, Candido C, Witchel SF. The hypothalamic- pituitary-Adrenal axis in critical illness. Rev Endocr Metab Disord 2007; 8: 365-73
59. Meduri GU, Muthiah MP, Carratu P, Eltorky M, Chrousos GP. Nuclear factor-kappaB-And glucocorticoid receptor alpha-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005; 12: 321-38
60. Hahner S, Loeffler M, Fassnacht M, et al. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 2007; 92: 3912-22
61. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G. Premature mortality in patients with Addison's disease: A population-based study. J Clin Endocrinol Metab 2006; 91: 4849-53
62. Caputo M, Alwair H, Rogers CA, et al. Myocardial, inflammatory, and stress responses in off-pump coronary artery bypass graft surgery with thoracic epidural anesthesia. Ann Thorac Surg 2009; 87: 1119-26
63. Roth-Isigkeit AK, Schmucker P. Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery. Steroids 1997; 62: 695-9
64. Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995; 80: 1238-42
65. Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology 1993; 187: 403-16
66. Judd AM, Call GB, Barney M, et al. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Ann N Y Acad Sci 2000; 917: 628-37
67. Winter JS, Gow KW, Perry YS, Greenberg AH. A stimulatory effect of interleukin-1 on adrenocortical cortisol secretion mediated by prostaglandins. Endocrinology 1990; 127: 1904-9
68. Xia HM, Fang Y, Huang PL. Tumor necrosis factor alpha affect hydrocortisone expression in mice adrenal cortex cells mainly through tumor necrosis factor alpha-receptor 1. Chin Med J (Engl) 2011; 124: 2728-32
69. Tkachenko IV, Jaaskelainen T, Jaaskelainen J, Palvimo JJ, Voutilainen R. Interleukins 1alpha and 1beta as regulators of steroidogenesis in human NCI-H295R adrenocortical cells. Steroids 2011; 76: 1103-15
70. Barney M, Call GB, McIlmoil CJ, et al. Stimulation by interleukin-6 and inhibition by tumor necrosis factor of cortisol release from bovine adrenal zona fasciculata cells through their receptors. Endocrine 2000; 13: 369-77
71. Salas MA, Evans SW, Levell MJ, Whicher JT. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol 1990; 79: 470-3
72. Bethin KE, Vogt SK, Muglia LJ. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci U S A 2000; 97: 9317-22
73. Path G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: Expression and effects on steroidogenesis. J Clin Endocrinol Metab 1997; 82: 2343-9
74. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD. Ultradian rhythm of basal corticosterone release in the female rat: Dynamic interaction with the response to acute stress. Endocrinology 1998; 139: 443-50
75. Rankin J, Walker JJ, Windle RJ, Lightman SL, Terry Jr. Characterizing dynamic interactions between ultradian glucocorticoid rhythmicity and acute stress using the phase response curve. PLoS One 2012; 7: E30978
76. Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: A systematic review of the literature. Arch Surg 2008; 143: 1222-6
77. Zaghiyan K, Melmed G, Murrell Z, Fleshner P. Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study. Surgery 2012; 152: 158-63
78. Zaghiyan K, Melmed G, Murrell Z, Fleshner P. Are high-dose perioperative steroids necessary in patients undergoing colorectal surgery treated with steroid therapy within the past 12 months? Am Surg 2011; 77: 1295-9
79. Waterhouse R. Case of suprarenal apoplexy. Lancet 1911; 1: 577
80. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-49
81. Melby JC, Spink WW. Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J Clin Invest 1958; 37: 1791-8
82. Spink WW. ACTH and adrenocorticosteroids as therapeutic adjuncts in infectious diseases. N Engl J Med 1957; 257: 979-83
83. Molenaar N, Johan Groeneveld AB, Dijstelbloem HM, et al. Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med 2011; 37: 1986-93
84. Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroidbinding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001; 27: 1584-91
85. Venkatesh B, Mortimer RH, Couchman B, Hall J. Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: A prospective study. Anaesth Intensive Care 2005; 33: 201-9
86. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. Jama 2000; 283: 1038-45
87. Cohen J, Smith ML, Deans RV, et al. Serial changes in plasma total cortisol, plasma free cortisol, and tissue cortisol activity in patients with septic shock: An observational study. Shock 2012; 37: 28-33
88. Arafah BM, Nishiyama FJ, Tlaygeh H, Hejal R. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: A surrogate marker of the circulating free cortisol. J Clin Endocrinol Metab 2007; 92: 2965-71
89. Henley DE, Leendertz JA, Russell GM, et al. Development of an automated blood sampling system for use in humans. J Med Eng Technol 2009; 33: 199-208
90. Annane D, Bellissant E, Bollaert P, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating severe sepsis and septic shock (Review). The Cochrane Library 2010; 12; CD004423
91. Dieleman JM, van Paassen J, van Dijk D, et al. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev 2011; CD005566
92. Group ESR. Corticosteroids for severe sepsis and septic shock. In: Annane D, ed. Clinical Evidence in Intensive Care. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft, 2011; 283-91
93. Kronenberg HM, Melmed S, Polonsky KS, Reed Larsen P, eds. Williams Textbook of Endocrinology. Philadelphia: Saunders, 2007
94. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111-24
95. Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med 1999; 27: 33A
96. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26: 645-50
97. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27: 723-32
98. Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33: 2457-64
99. Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: Effects on microalbuminuria. Crit Care Med 2006; 34: 2334-9
100. Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: A prospective randomized trial. Crit Care 2007; 11: R21
101. Yildiz O, Doganay M, Aygen B, Guven M, Kelestimur F, Tutuu A. Physiological-dose steroid therapy in sepsis. Crit Care 2002; 6: 251-9
102. Cicarelli DD, Vieira JE, Bensenor FE. Early dexamethasone treatment for septic shock patients: A prospective randomized clinical trial. Sao Paulo Med J 2007; 125: 237-41
103. Hinshaw LPP, Young E, Sprung C, et al. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med 1987; 317: 659-65
104. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of shigh-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317: 653-8
105. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138: 62-8
106. Klastersky J, Cappel R, Debusscher L. Effectiveness of betamethasone in management of severe infections. A double-blind study. N Engl J Med 1971; 284: 1248-50
107. Lucas CE, Ledgerwood AM. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Arch Surg 1984; 119: 537-41
108. Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984; 311: 1137-43
109. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976; 184: 333-41
110. Care Quality Commission SfCSiGBaI. Heart Surgery in the United Kingdom. 2009. Available from http://heartsurgery.cqc.org.uk/ Survival.aspx (accessed 5 July 2012
111. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: A dose-response meta-Analysis. Circulation 2009; 119: 1853-66
112. Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-Analysis of randomized trials. Eur Heart J 2008; 29: 2592-600
113. Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative highdose dexamethasone for cardiac surgery: A randomized controlled trial. JAMA 2012; 308: 1761-7
114. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-Acquired pneumonia: A preliminary randomized study. Am J Respir Crit Care Med 2005; 171: 242-8
115. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-71
116. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987; 92: 1032-6